Renyi Su
Impact in
-
- Pharmacological Effects of Natural Compounds
- Plant-based Medicinal Research
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
-
- Renal Transplantation Outcomes and Treatments 4
- Co-authors
- Xiao Xu (19 shared papers)Xuyong Wei (20 shared papers)Xiaolong Liao (1 shared paper)Xiping Xu (1 shared paper)Jian Wang (1 shared paper)Yan Liu (1 shared paper)Bo Zhu (1 shared paper)Yan Shi (1 shared paper)
- Journals
- Liver International (2 papers)International Journal of Surgery (2 papers)Clinical and Translational Medicine (1 paper)Cell Communication and Signaling (1 paper)American Journal of Transplantation (1 paper)
- Partner nations
- ChinaMadagascarAustralia
In The Last Decade
Renyi Su
29 papers receiving 252 citations
Peers
Comparison fields: 5 of 48
- Pharmacology 31
- Hepatology 26
- Complementary and alternative medicine 26
- Cancer Research 38
- Biological Psychiatry 5
Countries citing papers authored by Renyi Su
This map shows the geographic impact of Renyi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renyi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renyi Su more than expected).
Fields of papers citing papers by Renyi Su
This network shows the impact of papers produced by Renyi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renyi Su. The network helps show where Renyi Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Renyi Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 96 | |
| 2 | 2024 | 22 | |
| 3 | 2022 | 14 | |
| 4 | 2022 | 12 | |
| 5 | 2021 | 11 | |
| 6 | 2023 | 11 | |
| 7 | 2024 | 9 | |
| 8 | 2020 | 9 | |
| 9 | 2023 | 9 | |
| 10 | Prediction of tumor recurrence by distinct immunoprofiles in liver transplant patients based on mass cytometry. | 2022 | 9 |
| 11 | 2022 | 8 | |
| 12 | 2022 | 5 | |
| 13 | 2023 | 5 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2025 | 4 | |
| 18 | 2024 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 2 |
About Renyi Su
Renyi Su is a scholar working on Hepatology, Transplantation, Cancer Research, Epidemiology and Molecular Biology, having authored 34 papers that have together received 258 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Organ Transplantation Techniques and Outcomes (5 papers), Renal Transplantation Outcomes and Treatments (4 papers), Liver Disease Diagnosis and Treatment (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), RNA modifications and cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Pharmacology (31 citations), Hepatology (26 citations), Complementary and alternative medicine (26 citations), Cancer Research (38 citations) and Biological Psychiatry (5 citations). Renyi Su has collaborated with scholars based in China, Madagascar and Australia. Frequent co-authors include Xiao Xu, Xuyong Wei, Xiaolong Liao, Xiping Xu, Jian Wang, Yan Liu, Bo Zhu, Yan Shi, Wei Zhou and Xuefeng Guan. Their work appears in journals such as Liver International, International Journal of Surgery, Clinical and Translational Medicine, Cell Communication and Signaling and American Journal of Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.